125 related articles for article (PubMed ID: 23722052)
1. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases.
Mahajan N; Dhawan V
Int J Cardiol; 2013 Oct; 168(3):1788-94. PubMed ID: 23722052
[TBL] [Abstract][Full Text] [Related]
2. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases.
Koyama H; Yamamoto H; Nishizawa Y
Mol Med; 2007; 13(11-12):625-35. PubMed ID: 17932553
[TBL] [Abstract][Full Text] [Related]
3. Mouse RAGE Variant 4 Is a Dominant Membrane Receptor that Does Not Shed to Generate Soluble RAGE.
Peng Y; Horwitz N; Lakatta EG; Lin L
PLoS One; 2016; 11(9):e0153657. PubMed ID: 27655067
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening of RAGE inhibitors using molecular docking.
Devi Alaparthi M; Gopinath G; Bandaru S; Sankeshi V; Mangalarapu M; Sudha Nagamalla S; Sudhakar K; Roja Rani A; Rao Sagurthi S
Bioinformation; 2016; 12(3):124-130. PubMed ID: 28149046
[TBL] [Abstract][Full Text] [Related]
5. Why Epidemics Rage at Night.
West J Med Surg; 1850 Sep; 6(3):265-266. PubMed ID: 38209662
[No Abstract] [Full Text] [Related]
6. The Rage for Invention.
West J Med Surg; 1843 Jun; 7(6):468. PubMed ID: 38208101
[No Abstract] [Full Text] [Related]
7. From celebration to rage.
McMahon A
J Res Nurs; 2022 Dec; 27(8):681-684. PubMed ID: 36530748
[No Abstract] [Full Text] [Related]
8. Cellular signalling of the receptor for advanced glycation end products (RAGE).
Xie J; Méndez JD; Méndez-Valenzuela V; Aguilar-Hernández MM
Cell Signal; 2013 Nov; 25(11):2185-97. PubMed ID: 23838007
[TBL] [Abstract][Full Text] [Related]
9. Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.
Malik P; Chaudhry N; Mittal R; Mukherjee TK
Biochim Biophys Acta; 2015 Sep; 1850(9):1898-904. PubMed ID: 26028296
[TBL] [Abstract][Full Text] [Related]
10. Role of AGEs-RAGE system in cardiovascular disease.
Fukami K; Yamagishi S; Okuda S
Curr Pharm Des; 2014; 20(14):2395-402. PubMed ID: 23844818
[TBL] [Abstract][Full Text] [Related]
11. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
12. Effects of RAGE Deletion on the Cardiac Transcriptome during Aging.
Scavello F; Piacentini L; Castiglione S; Zeni F; Macrì F; Casaburo M; Vinci MC; Colombo GI; Raucci A
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232442
[TBL] [Abstract][Full Text] [Related]
13. A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation.
Karamichalakis N; Kolovos V; Paraskevaidis I; Tsougos E
J Cardiovasc Dev Dis; 2022 Jul; 9(8):. PubMed ID: 35893226
[TBL] [Abstract][Full Text] [Related]
14. Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
Fotheringham AK; Gallo LA; Borg DJ; Forbes JM
Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807857
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
16. Proximal tubular RAGE mediated the renal fibrosis in UUO model mice via upregulation of autophagy.
Liu B; Sun T; Li H; Qiu S; Li Y; Zhang D
Cell Death Dis; 2022 Apr; 13(4):399. PubMed ID: 35461309
[TBL] [Abstract][Full Text] [Related]
17. Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses.
Page TH; Chiappo D; Brunini F; Garnica J; Blackburn J; Dudhiya F; Prendecki M; McAdoo SP; Pusey CD
Rheumatology (Oxford); 2022 Feb; 61(2):834-845. PubMed ID: 33974049
[TBL] [Abstract][Full Text] [Related]
18. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
Yang P; Feng J; Peng Q; Liu X; Fan Z
Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.
Wang X; Xu T; Mungun D; Zhou C; Zha Z; Lu M; Fen C; Guo Y
Dis Markers; 2019; 2019():4528382. PubMed ID: 31275446
[TBL] [Abstract][Full Text] [Related]
20. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging.
Scavello F; Zeni F; Tedesco CC; Mensà E; Veglia F; Procopio AD; Bonfigli AR; Olivieri F; Raucci A
Aging (Albany NY); 2019 Mar; 11(6):1648-1663. PubMed ID: 30903794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
